Levetiracetam Tablet, Film Coated
Product Images NDC 68084-882

Product Visual Gallery

This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 68084-882). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1000 mg Blister

This text seems to be a list of various forms of Levetiracetam medication, with different measurements and types. The medication may be used to treat seizures or epilepsy.*

FDA Label Image

1000 mg Carton

Levetiracetam is a prescription drug that comes in the form of tablets. Each package contains 100 tablets (10 x 10). It is a USP controlled substance and contains film-coated Levetracetam USP. The drug is manufactured by Aurobindo Pharma USA, Inc., and packaged and distributed by American Health Packaging in Columbus, Ohio. The package should be kept out of reach of children, and the tablets should not be used if the blister is broken. The text includes the NDC code 68084-893-01.*

FDA Label Image

250 mg Blister

FDA Label Image

250 mg Carton

This is a medication package of Levetiracetam tablets, USP, containing 100 tablets (10 x 10) with a strength of RxOnly. The National Drug Code (NDC) for this medication is 68084-859-01. The package needs to be stored between 20° and 25°C (58°F to 77°F) with permissible excursions between 15°C to 30°C (59°F to 86°F). The package is to be kept away from children and should not be used if the blister is open or broken. The package was manufactured and distributed by Amerin Gearh Packaging.*

FDA Label Image

500 mg Blister

FDA Label Image

500 mg Carton

This is a description of a medication called Levetiracetam, which is available in the form of tablets. The tablets are packaged in a bottle containing 100 tablets. The recommended dosage is mentioned on the package and it is advised to refer to the prescribing information for more details. The tablets are to be stored between 20°C to 25°C and away from children. The package includes information on the manufacturer and distributor, which is Aurobindo Pharma USA Inc. and American Health Packaging respectively. Product protection guidelines are also mentioned on the package.*

FDA Label Image

750 mg Blister

FDA Label Image

750 mg Carton

This is a description of a medication called Levetiracetam, which comes in the form of tablets. The tablets come in a bottle of 100, which is made up of 10 packs of 10 tablets each. It is only to be prescribed by a doctor and comes with an accompanying medication guide for patients. The tablets contain 750mg of the active ingredient, Levetiracetam USP, and should be kept at a temperature between 15° and 30°C. It is manufactured by Aurobindo Pharma USA, packaged, and distributed by American Health Packaging in Columbus.*

FDA Label Image

Ahp85901

FDA Label Image

Ahp87001

FDA Label Image

Ahp88201

FDA Label Image

Ahp89301

FDA Label Image

Figure 1

This is a table or chart displaying percentages of "Patients" for different treatment groups: Placebo, Lovetacetam 100 mg/day, and Lovetacetam 3000 mg/day. However, there is no clear indication of what the percentages represent, making it difficult to provide a more specific or useful description.*

FDA Label Image

Figure 2

FDA Label Image

Figure 3

This appears to be a table showing the percentage of patients who were given placebo and levocetam 3000 my/day. However, there is no clear indication of what the percentages represent. Therefore, the usefulness of this text is not-available.*

FDA Label Image

Figure 4

FDA Label Image

Figure 5

FDA Label Image

Figure 6

This appears to be a table showing the percentage of patients in a study taking either a placebo or levetiracetam (a medication used to treat seizures). The percentages likely represent the proportion of patients who experienced a certain outcome or side effect. There are some blank spaces in the table, and there is no clear indication of what the percentages correspond to.*

FDA Label Image

Structure

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.